These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32980695)

  • 41. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between preoperative skeletal muscle mass depletion and poor relapse-free survival in patients with gastrointestinal stromal tumors after complete resection.
    Jia J; Zhang L; Wang T; Yang W; Lyu J; Zeng X; Li X; Zeng X; Liu W; Tao K; Zhang P
    Nutrition; 2022 Jun; 98():111636. PubMed ID: 35452975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of prognostic nutritional index with prognosis of gastrointestinal stromal tumors.
    Sun J; Mei Y; Zhu Q; Shou C; Tjhoi WEH; Yang W; Yu H; Zhang Q; Liu X; Yu J
    J Cancer; 2019; 10(12):2679-2686. PubMed ID: 31258776
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of Gold's nomogram for predicting recurrence-free survival in gastrointestinal stromal tumors in Indian patients.
    Valappil FK; Rajan R; Natesh B; Sindhu RS; Raviram S; Mathew J
    Indian J Gastroenterol; 2016 May; 35(3):225-8. PubMed ID: 27256432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

  • 46. Development of an innovative nomogram of risk factors to predict postoperative recurrence of gastrointestinal stromal tumors.
    Guan SH; Wang Q; Ma XM; Qiao WJ; Li MZ; Lai MG; Wang C
    World J Gastrointest Surg; 2022 Sep; 14(9):940-949. PubMed ID: 36185569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
    Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
    Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiomics nomogram for predicting the malignant potential of gastrointestinal stromal tumours preoperatively.
    Chen T; Ning Z; Xu L; Feng X; Han S; Roth HR; Xiong W; Zhao X; Hu Y; Liu H; Yu J; Zhang Y; Li Y; Xu Y; Mori K; Li G
    Eur Radiol; 2019 Mar; 29(3):1074-1082. PubMed ID: 30116959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Associations of Preoperative Platelet-to-lymphocyte Ratio and Derived Neutrophil-to-lymphocyte Ratio with thePrognosis of Gastrointestinal Stromal Tumor].
    Yin XN; Tang SM; Yin Y; Shen CY; Zhang B; Chen ZX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):239-243. PubMed ID: 28612534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery.
    Huang YY; Wu LL; Liu X; Liang SH; Ma GW
    BMC Cancer; 2021 Jul; 21(1):847. PubMed ID: 34294070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinicopathological features and prognosis of 59 patients with platelet-derived growth factor α-mutant gastrointestinal stromal tumor].
    Sun XF; Gao XD; Yuan W; Sun JY; Fu M; Xue AW; Li H; Shu P; Fang Y; Hou YY; Shen KT; Sun YH; Qin J; Qin XY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):880-887. PubMed ID: 32927513
    [No Abstract]   [Full Text] [Related]  

  • 53. Prediction of recurrence-free survival and adjuvant therapy benefit in patients with gastrointestinal stromal tumors based on radiomics features.
    Wang FH; Zheng HL; Li JT; Li P; Zheng CH; Chen QY; Huang CM; Xie JW
    Radiol Med; 2022 Oct; 127(10):1085-1097. PubMed ID: 36057930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk Factors and Prognostic Analysis of Gastrointestinal Stromal Tumor Recurrence-Metastasis.
    Chen S; Sang K; Chen W; Jin J; Chen X; Zhu G; Wang P; Cai Y
    Comput Math Methods Med; 2022; 2022():1127146. PubMed ID: 35898476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of prognostic prediction models for rectal gastrointestinal stromal tumor.
    Jiaxin L; Peiyun Z; Zheng T; Wei Y; Shanshan S; Lei R; Zhengwen X; Yong F; Xiaodong G; Anwei X; Kuntang S; Yingyong H
    Aging (Albany NY); 2020 Jun; 12(12):11416-11430. PubMed ID: 32561689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Nomogram for Predicting Cancer-Specific Survival of Patients with Gastrointestinal Stromal Tumors.
    Liu M; Song C; Zhang P; Fang Y; Han X; Li J; Wu W; Chen G; Sun J
    Med Sci Monit; 2020 May; 26():e922378. PubMed ID: 32449506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor.
    Chang WL; Yang WC; Zeng XY; Li CG; Xiong Z; Wang T; Zhang RZ; Tao KX; Zhang P
    BMC Gastroenterol; 2020 Apr; 20(1):124. PubMed ID: 32321434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.
    Rossi S; Miceli R; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Toffolatti L; Laurino L; Mariani L; Vinaccia V; Gnocchi C; Gronchi A; Casali PG; Dei Tos AP
    Am J Surg Pathol; 2011 Nov; 35(11):1646-56. PubMed ID: 21997685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor.
    Liu X; Lin E; Sun Y; Liu X; Li Z; Jiao X; Li Y; Guo D; Zhang P; Feng X; Chen T; Niu Z; Zhou Z; Qiu H; Zhou Y
    Front Med (Lausanne); 2022; 9():777181. PubMed ID: 35360729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
    Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
    JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.